Cardiology News and Research

Latest Cardiology News and Research

Organ-transplant drug may aid in lupus fight

A compound related to a drug used in humans to prevent organ-transplant rejection attacks a key biochemical process in the faulty immune cells of lupus-prone mice, suggesting a possible new approach to combating the disease, UT Southwestern Medical Center researchers have found.

15 Aug 2007

Experts say any exercise is better than none

Scientists in Britain say even low levels of weekly exercise could help reduce blood pressure and improve fitness, and walking as little as three times a week could have health benefits.

15 Aug 2007

Pregnant women advised to cut out junk food for their child's sake

British researchers are warning pregnant women that a penchant for junk food may be condemning their children to crave the same diet.

14 Aug 2007

Drug to treat cluster headaches may affect the heart

Researchers are warning that a drug increasingly being used to prevent cluster headaches can cause heart problems.

14 Aug 2007

Vitamin supplements no benefit to women's heart health

Researchers in the U.S. say middle-aged women at risk for heart disease derive little benefit from taking vitamins C, E or beta carotene.

14 Aug 2007

That pot belly puts you at risk of heart disease

According to researchers in the U.S. people with pot bellies are more at risk of having heart disease than those whose fat is spread evenly over the rest of their body.

14 Aug 2007

Why is heart disease so prevalent among diabetics?

Heart disease hits people with diabetes twice as often as people without diabetes.

13 Aug 2007

LifeCycle Pharma and Sciele Pharma announce FDA approval of new formulation of Fenofibrate

LifeCycle Pharma and Sciele Pharma announce FDA approval of fenofibrate in 120 mg. and 40 mg. dosage strengths. Sciele Pharma expects U.S. market launch by the end of 2007.

13 Aug 2007

Impaired energy production in heart muscle may underlie heart failure in some hypertensive patients

Many people with long-standing high blood pressure develop heart failure. But some don't. Daniel P. Kelly, M.D., and colleagues at Washington University School of Medicine in St. Louis and other institutions are trying to figure out what could explain that difference.

13 Aug 2007

Diovan (valsartan) granted pediatric exclusivity by FDA

Diovan (valsartan) has been granted pediatric exclusivity by the US Food and Drug Administration (FDA) based on studies conducted in children with high blood pressure.

13 Aug 2007

Warfarin versus aspirin for stroke prevention

A study tracking nearly 1,000 over-75s at high risk of stroke has found that the anticoagulant drug warfarin cuts the risk by half in this older population without causing more side-effects than alternatives.

13 Aug 2007

Genomic factors may play a role in alcohol and tobacco use

Alcohol and smoking can be harmful, if not deadly. While the desire for these substances can be due to environmental cues, genomic factors also play an important role.

13 Aug 2007

Improving the quality of primary care could prevent 4 million hospitalizations each year

More than 4 million hospitalizations potentially could be prevented each year by improving the quality of primary care, enhancing patients' access to effective treatments, and getting more Americans to adopt healthy behaviors, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

13 Aug 2007

Scientists take plumber's approach to Alzheimer's

Scientists are trying a plumber's approach to rid the brain of the amyloid buildup that plagues Alzheimer's patients: Simply drain the toxic protein away.

13 Aug 2007

FDA taking no chances when it comes to drug safety

These days the U.S. Food and Drug Administration (FDA) is taking no chances when it comes to the safety of new drugs.

13 Aug 2007

Cashew nut allergy more severe in children than peanut allergy

Researchers in Britain say peanut allergies may be more infamous but cashews seem to trigger more severe allergic reactions in children.

13 Aug 2007

DIY hole-in-the-heart repair kit

Specialists in the UK have found a way to treat a common heart defect using the body's natural healing power.

12 Aug 2007

Writing off Avandia may be premature

Rosiglitazone, a drug marketed by GlaxoSmithKline as Avandia, for the treatment of type 2 diabetes, came under fire after an article published online May 21 by the New England Journal of Medicine linked it to significantly increased risk of heart attack and cardiovascular death.

12 Aug 2007